The country's strategic drug reserves are in good condition. The reason for the increase in the price of imported insulin. The country has good resilience to provide long-term medicines. Locally produced insulin is available in sufficient quantity and abundance in the country. Due to problems with import routes and foreign exchange allocation in the commercial market rate for imported insulins, the price increase of these products is certain. Patients using Iranian insulin will not face any particular problem in terms of cost.